IRIS UniCatt

Martinotti, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.783
NA - Nord America 6.030
AS - Asia 4.025
SA - Sud America 727
AF - Africa 97
OC - Oceania 38
Continente sconosciuto - Info sul continente non disponibili 4
Totale 19.704
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.877
IT - Italia 4.277
SG - Singapore 1.841
DE - Germania 1.719
CN - Cina 958
BR - Brasile 591
SE - Svezia 546
FR - Francia 535
UA - Ucraina 421
VN - Vietnam 358
GB - Regno Unito 304
NL - Olanda 183
IE - Irlanda 180
IN - India 163
FI - Finlandia 141
ID - Indonesia 122
RU - Federazione Russa 110
JP - Giappone 107
HK - Hong Kong 85
BD - Bangladesh 82
TR - Turchia 75
CA - Canada 73
CH - Svizzera 67
PL - Polonia 54
MX - Messico 52
ES - Italia 51
AR - Argentina 46
AU - Australia 31
BE - Belgio 31
IQ - Iraq 27
ZA - Sudafrica 24
RO - Romania 23
AT - Austria 21
IR - Iran 21
SA - Arabia Saudita 20
CL - Cile 19
AL - Albania 16
CO - Colombia 16
VE - Venezuela 16
MA - Marocco 15
CI - Costa d'Avorio 14
EC - Ecuador 14
PK - Pakistan 14
CZ - Repubblica Ceca 13
HU - Ungheria 13
NP - Nepal 13
IL - Israele 12
PH - Filippine 11
JO - Giordania 10
PE - Perù 10
AE - Emirati Arabi Uniti 9
KE - Kenya 9
KR - Corea 9
LT - Lituania 9
EG - Egitto 8
GR - Grecia 8
KZ - Kazakistan 8
MT - Malta 8
PT - Portogallo 8
TH - Thailandia 8
TW - Taiwan 8
UZ - Uzbekistan 8
MY - Malesia 7
NZ - Nuova Zelanda 7
OM - Oman 7
RS - Serbia 7
TN - Tunisia 7
UY - Uruguay 7
AM - Armenia 6
DZ - Algeria 6
HR - Croazia 6
DO - Repubblica Dominicana 5
LB - Libano 5
LV - Lettonia 5
PS - Palestinian Territory 5
TT - Trinidad e Tobago 5
AZ - Azerbaigian 4
KG - Kirghizistan 4
LU - Lussemburgo 4
NG - Nigeria 4
PY - Paraguay 4
BO - Bolivia 3
BY - Bielorussia 3
DK - Danimarca 3
ET - Etiopia 3
JM - Giamaica 3
MC - Monaco 3
NO - Norvegia 3
QA - Qatar 3
BG - Bulgaria 2
BH - Bahrain 2
BZ - Belize 2
CR - Costa Rica 2
EE - Estonia 2
EU - Europa 2
GT - Guatemala 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
MD - Moldavia 2
Totale 19.673
Salva come PNG Salva come JPEG
Città #
Singapore 942
Chandler 767
Ashburn 673
San Jose 622
Milan 511
Rome 437
Jacksonville 211
San Mateo 189
Dublin 172
Beijing 163
Wilmington 147
New York 138
Nanjing 123
Ho Chi Minh City 119
Lauterbourg 115
Los Angeles 113
Jakarta 108
Woodbridge 97
Hanoi 94
St Louis 94
The Dalles 85
Dearborn 83
Hefei 78
Tokyo 78
Nürnberg 76
Munich 72
Boston 71
Frankfurt am Main 71
Ann Arbor 67
Redwood City 67
Turin 66
Hong Kong 63
Bologna 61
Florence 61
Moscow 59
Houston 58
Lawrence 56
Marseille 56
Naples 56
São Paulo 56
Seattle 55
Norwalk 50
Bremen 49
Nanchang 48
Burlington 46
Buffalo 43
Lancaster 42
Paris 42
Fairfield 41
Princeton 40
Santa Clara 40
Dallas 39
Catania 38
Genoa 38
Bari 36
Chicago 36
Council Bluffs 36
Verona 36
Palermo 35
Brescia 34
Cattolica 34
Guangzhou 34
Helsinki 34
Boardman 33
Falls Church 32
University Park 30
Changsha 27
Mountain View 27
Tianjin 26
Warsaw 25
Hebei 24
Izmir 23
London 23
Brussels 22
Hangzhou 22
Mexico City 22
Shanghai 22
Perugia 20
Shenyang 20
Chennai 19
Kent 19
Pune 19
Cambridge 18
Da Nang 18
Fremont 18
Haiphong 18
Toronto 18
Atlanta 17
Messina 17
Padova 17
Memphis 16
Modena 16
Orem 16
Torino 16
Jiaxing 15
Kunming 15
Tirana 15
Abidjan 14
Brooklyn 14
Montreal 14
Totale 8.848
Salva come PNG Salva come JPEG
Nome #
L efficacia del topiramato a basso dosaggio in pazienti alcolisti in fase di post-disintossicazione 3.137
Psychometric characteristic of the Italian version of the Temperament and Character Inventory--revised, personality, psychopathology, and attachment styles 653
Quetiapine as add-on treatment for Bipolar I Disorder with comorbid compulsive buying and physical exercise addiction 567
Comorbilità tra Disturbi da Uso di Sostanze e disturbi affettivi 485
Craving Typology Questionnaire (CTQ): a scale for alcohol craving in normal controls and alcoholics 413
Description and validation of a questionnaire for the detection of meteoropathy and meteorosensitivity: the METEO-Q 360
Bipolar disorder and gambling disorder comorbidity: current evidence and implications for pharmacological treatment 318
Behavioural addictions in bipolar disorder patients: Role of impulsivity and personality dimensions 291
Pregabalin versus naltrexone in alcohol dependence: a randomised, double-blind, comparison trial 266
Pregabalin, tiapride and lorazepam in alcohol withdrawal syndrome: a multi-centre, randomized, single-blind comparison trial. 265
Bipolar disorder: "pure" versus mixed depression over a 1-year follow-up 218
[Diagnosis of deficit and attention/hyperactivity disorders (ADHD) in patients with bipolar or unipolar depression: an experimental study] 211
Bipolar disorder: "pure" versus mixed depression over a 1-year follow-up. 211
Further evidence supporting the association between 5HTR2C gene and bipolar disorder 201
Role of Substance Abuse Comorbidity and Personality on the Outcome of Depression in Bipolar Disorder: Harm Avoidance Influences Medium-Term Treatment Outcome. 198
Problematic mobile phone use in adolescence: A cross-sectional study 196
[Diagnosis of deficit and attention/hyperactivity disorders (ADHD) in patients with bipolar or unipolar depression: an experimental study]. 195
Bipolar disorder: "pure" versus mixed depression over a 1-year follow-up 185
Adult attention-deficit/hyperactivity disorder in major depressed and bipolar subjects: role of personality traits and clinical implications 178
Factors associated with the course of symptoms in bipolar disorder during a 1-year follow-up: depression vs. sub-threshold mixed state 175
Low-dose topiramate in alcohol dependence: a single-blind, placebo-controlled study 175
Alcohol protracted withdrawal syndrome: the role of anhedonia 171
Suicide by pencil 170
Topiramate in Alcohol Use Disorders: Review and Update. 168
Pregabalin in outpatient detoxification of subjects with mild-to-moderate alcohol withdrawal syndrome. 166
Anhedonia in Parkinson's disease patients with and without pathological gambling: A case-control study 165
Role of substance abuse comorbidity and personality on the outcome of depression in bipolar disorder: harm avoidance influences medium-term treatment outcome 162
Behavioural addictions in adolescents and young adults: results from a prevalence study. 160
Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up 159
PRELIMINARY ANALYSIS OF GENES INVOLVED IN INFLAMMATORY, OXIDATIVE PROCESSES AND CA2+SIGNALING IN BIPOLAR DISORDER AND COMORBIDITY FOR SUBSTANCE USE DISORDER 158
Pregabalin augmentation in treatment-resistant obsessive-compulsive disorder: a 16-week case series 158
Gender Differences and Psychopathological Features Associated With Addictive Behaviors in Adolescents. 157
Acetyl-L-carnitine for alcohol craving and relapse prevention in anhedonic alcoholics: a randomized, double-blind, placebo-controlled pilot trial. 153
Il trattamento della schizofrenia 152
Oxcarbazepine in bipolar disorder: a critical review of the literature 150
Allostasis as a conceptual framework linking bipolar disorder and addiction 150
Serotoninergic and dopaminergic genes in bipolar disorder and response to treatments in bipolar depression. Investigation on a well-characterized naturalistic sample 149
Further evidence supporting the influence of brain-derived neurotrophic factor on the outcome of bipolar depression: independent effect of brain-derived neurotrophic factor and harm avoidance 148
Acetyl-l-Carnitine in the treatment of anhedonia, melancholic and negative symptoms in alcohol dependent subjects 147
Targeting the glutamatergic system to treat pathological gambling: current evidence and future perspectives 147
Agomelatine increases BDNF serum levels in depressed patients in correlation with the improvement of depressive symptoms 147
Behavioural addictions in adolescents and young adults: results from a prevalence study 144
Gabapentin as add-on treatment for somatoform disorder: a case report 143
The assessment of post-detoxification anhedonia: influence of clinical and psychosocial variables 142
Acetyl-L-Carnitine in the management of pain during methadone withdrawal syndrome 142
Aripiprazole, alcohol and substance abuse: a review 140
Enhanced BDNF serum levels in patients with severe pathological gambling 135
Alcohol drinking patterns in young people: A survey-based study 135
Neural correlates of cognitive control in gambling disorder: a systematic review of fMRI studies 135
Cocaine use disorders and serum magnesium profile 133
Plasma levels of n-3 fatty acids in bipolar patients: Deficit restricted to DHA 133
Dead under the bed: a case of Diogenes syndrome? 133
Amantadine in the treatment of pathological gambling: a case report 133
Dopaminergic and clinical correlates of high-frequency repetitive transcranial magnetic stimulation in gambling addiction: a SPECT case study. 132
Does DRD2 Taq1A Mediate Aripiprazole-Induced Gambling Disorder? A Pharmacogenetic Hypothesis 132
Oxcarbazepine improves mood in patients with epilepsy. 131
Aripiprazole in the treatment of patients with alcohol dependence: a double-blind, comparison trial vs. naltrexone 131
Oxcarbazepine improves mood in patients with epilepsy 129
Punding in non-demented Parkinson's disease patients: Relationship with psychiatric and addiction spectrum comorbidity 129
Transcranial electrical and magnetic stimulation (tES and TMS) for addiction medicine: A consensus paper on the present state of the science and the road ahead 129
Reduced hedonic capacity in euthymic bipolar subjects: a trait-like feature? 126
Who`s the Leader, Mania or Depression? Predominant Polarity and Alcohol/Polysubstance Use in Bipolar Disorders 126
Mono- and polysubstance dependent subjects differ on social factors, childhood trauma, personality, suicidal behaviour, and comorbid Axis I diagnoses 124
The emerging role of melatonin agonists in the treatment of major depression: focus on agomelatine 122
Enhanced BDNF serum levels in patients with severe pathological gambling 122
Who's the Leader, Mania or Depression? Predominant Polarity and Alcohol/Polysubstance Use in Bipolar Disorders 122
Striatal presynaptic dopaminergic dysfunction in gambling disorder: A 123 I-FP-CIT SPECT study. 122
Quetiapine decreases alcohol consumption, craving, and psychiatric symptoms in dually diagnosed alcoholics 121
A possible new option for migraine management: agomelatine 121
Chronic ketamine use increases serum levels of brain-derived neurotrophic factor. 120
Relationship between craving and plasma leptin concentrations in patients with cocaine addiction. 119
Management of aripiprazole-induced tardive Pisa syndrome: A case report and literature review 118
‘Suicide on Italian Instagram: Insights and implications for prevention and support’ 117
Empathy ability is impaired in alcohol-dependent patients 117
Striatal presynaptic dopaminergic dysfunction in gambling disorder: A 123I-FP-CIT SPECT study 116
Antidepressant treatment restores brain-derived neurotrophic factor serum levels and ameliorates motor function in Parkinson disease patients 115
Prevalence and intensity of basic symptoms among cannabis users: an observational study 113
Temperament and character inventory dimensions and anhedonia in detoxified substance-dependent subjects 113
Anhedonia in Parkinson's disease patients with and without pathological gambling: a case-control study 113
Anhedonia and substance dependence: clinical correlates and treatment options 110
Ecstasy (MDMA)-addicted subjects show increased serum levels of brain-derived neurotrophic factor, independently from a rise of drug-induced psychotic symptoms 109
Efficacy and safety of pregabalin in alcohol dependence 108
Agomelatine versus venlafaxine XR in the treatment of anhedonia in major depressive disorder: a pilot study 107
Harm avoidance moderates the influence of serotonin transporter gene variants on treatment outcome in bipolar patients 105
Nalmefene in Alcohol Use Disorder Subjects with Psychiatric Comorbidity: A Naturalistic Study. 105
Hopelessness, Dissociative Symptoms, and Suicide Risk in Major Depressive Disorder: Clinical and Biological Correlates 103
Poprawa nastroju u chorych na padaczke leczonych okskarbazepina 103
Paliperidone for treatment of obsessive compulsive resistant symptoms in schizophrenia: a case report. 101
Reduced fronto-temporal connectivity is associated with frontal gray matter density reduction and neuropsychological deficit in schizophrenia. 101
Dorsolateral Prefrontal Cortex Impairment in Methoxetamine-Induced Psychosis: An 18F-FDG PET/CT Case Study. 101
BDNF Val66Met polymorphism is associated with aggressive behavior in schizophrenia 100
Neuropsychological Performance in Alcohol Dependent Patients: A One-Year Longitudinal Study. 98
Exploring peripheral biomarkers in psychostimulant use: A systematic review on neurotrophins, stress-related hormones, oxidative stress molecules and genetic factors 97
Substance-related psychopathology and aggressiveness in a nightlife holiday resort: Results from a pilot study in a psychiatric inpatient unit in Ibiza 97
Ecstasy (MDMA)-addicted subjects show increased serum levels of brain-derived neurotrophic factor, independently from a rise of drug-induced psychotic symptoms. 91
Trends in alcohol-related deaths in the EU countries in 1980-2003 90
null 90
Major Depression in Comorbidity with Substance use Disorders: Patients' Features and Clinical-Neurobiological Rationale of Antidepressant Treatments 88
Pregabalin for alcohol dependence: a critical review of the literature 86
High depression symptomatology and mental pain characterize suicidal psychiatric patients 81
Totale 18.934
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.813
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.813
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202132 0 0 0 0 0 0 0 0 0 0 0 32
2021/20221.030 80 91 33 53 59 44 52 176 64 69 132 177
2022/20232.918 279 309 204 366 210 278 191 302 357 100 170 152
2023/20241.910 143 358 103 141 125 246 84 105 78 115 192 220
2024/20252.917 172 145 218 171 268 129 138 188 430 222 428 408
2025/20266.202 732 214 286 548 1.013 381 1.062 459 428 608 298 173
Totale 19.888